Estimates Revisions Freenome, Inc.

Stocks

End-of-day quote Nasdaq 10/09/2026			5-day change	1st Jan Change
14.79 ^USD	-6.10%		-9.32%	+13.51%

20/08	Guggenheim Initiates Freenome at Buy With $21 Price Target	MT
19/08	Freenome Registers Up To 75.2 Million Shares For Sale	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. Revenue rev.	1y. EPS revision
FREENOME, INC.	-	-
IOVANCE BIOTHERAPEUTICS, INC.
ADAPTIVE BIOTECHNOLOGIES CORPORATION
VERACYTE, INC.
CAREDX, INC.
BGI GENOMICS CO., LTD.
SEEGENE, INC.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Average
Weighted average by Cap.